The IMI is a collaboration between the European Union and the European pharmaceutical industry. As the world’s biggest life sciences public-private partnership, the IMI facilitates collaboration and provides funding for healthcare stakeholders to conduct pan-European projects to improve healthcare around various key themes. Consortia of healthcare stakeholders come together to apply for highly-competitive grants dedicated to these themes.
In December 2016, ICHOM – together with a selection of leading healthcare institutions across Europe – were successful in securing a substantial IMI grant for a 5-year project in cardiovascular diseases, focused on big data on outcomes. ICHOM will lend its expertise in outcomes measurement and value-based healthcare to this project, which is due to begin in early 2017.